Inhibition of Osteopontin Reduces Liver Metastasis of Human Pancreatic Cancer Xenografts Injected into the Spleen in a Mouse Model
-
- OHNO KEISUKE
- Department of Surgery, Sapporo Medical University School of Medicine
-
- NISHIMORI HIDEFUMI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- YASOSHIMA TAKAHIRO
- Laboratory of Sapporo Cancer and Integrative Medicine, Shinsapporo Keiaikai Hospital
-
- KAMIGUCHI KENJIRO
- Department of Pathology, Sapporo Medical University School of Medicine
-
- HATA FUMITAKE
- Doto Hospital
-
- FUKUI RIKA
- Department of Surgery, Sapporo Medical University School of Medicine
-
- OKUYA KOICHI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- KIMURA YASUTOSHI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- DENNO RYUICHI
- Department of Nursing, Sapporo Medical University School of Health Sciences
-
- KON SHIGEYUKI
- Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University
-
- UEDE TOSHIMITSU
- Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University
-
- SATO NORIYUKI
- Department of Pathology, Sapporo Medical University School of Medicine
-
- HIRATA KOICHI
- Department of Surgery, Sapporo Medical University School of Medicine
Search this Article
Author(s)
-
- OHNO KEISUKE
- Department of Surgery, Sapporo Medical University School of Medicine
-
- NISHIMORI HIDEFUMI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- YASOSHIMA TAKAHIRO
- Laboratory of Sapporo Cancer and Integrative Medicine, Shinsapporo Keiaikai Hospital
-
- KAMIGUCHI KENJIRO
- Department of Pathology, Sapporo Medical University School of Medicine
-
- HATA FUMITAKE
- Doto Hospital
-
- FUKUI RIKA
- Department of Surgery, Sapporo Medical University School of Medicine
-
- OKUYA KOICHI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- KIMURA YASUTOSHI
- Department of Surgery, Sapporo Medical University School of Medicine
-
- DENNO RYUICHI
- Department of Nursing, Sapporo Medical University School of Health Sciences
-
- KON SHIGEYUKI
- Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University
-
- UEDE TOSHIMITSU
- Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University
-
- SATO NORIYUKI
- Department of Pathology, Sapporo Medical University School of Medicine
-
- HIRATA KOICHI
- Department of Surgery, Sapporo Medical University School of Medicine
Journal
-
- Surgery today : the Japanese journal of surgery
-
Surgery today : the Japanese journal of surgery 40(4), 347-356, 2010-04-01
References: 33
-
1
- Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer
-
OETTLE H
JAMA 297, 267-277, 2007
Cited by (1)
-
2
- Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
-
O'BRIEN ER
Artesioscler Thromb 14, 1648-1656, 1994
Cited by (1)
-
3
- A new experimental mouse model of peritoneal dissemination of human gastric cancer cells : analysis of the mechanism of peritoneal dissemination using cDNA macroarrays
-
NOMURA H
Jpn J Cancer Res 92, 748-754, 2001
Cited by (1)
-
4
- Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes
-
YAMAGUCHI K
J Exp Clin Cancer Res 19, 113-120, 2000
Cited by (1)
-
5
- Metastatic-associated biological properties and differential gene expression profiles in established highly liver and peritoneal metastatic cell lines of human pancreatic cancer
-
OHNO K
J Exp Clin Cancer Res 22, 623-631, 2003
Cited by (1)
-
6
- Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis
-
YAMAMOTO N
J Clin Invest 112, 181-188, 2003
Cited by (1)
-
7
- Osteopontin : possible role in prostate cancer progression
-
THALMANN GN
Clin Cancer Res 5, 2271-2277, 1999
Cited by (1)
-
8
- Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
-
WU Y
Br J Cancer 83, 156-163, 2000
Cited by (1)
-
9
- Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer
-
RUDLAND PS
Cancer Res 62, 3417-3427, 2002
Cited by (1)
-
10
- Expression of osteopontin and osteonectin in breast cancer
-
KIM YW
J Korean Med Sci 13, 652-657, 1998
Cited by (1)
-
11
- Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma
-
SHIJUBO N
Am J Respir Crit Care Med 160, 1269-1273, 1999
Cited by (1)
-
12
- RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells
-
MI Z
Mol Ther 17, 153-161, 2008
Cited by (1)
-
13
- Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma
-
SUN BS
Hepatology 48, 1834-1842, 2008
Cited by (1)
-
14
- Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis
-
ZHAO J
Gastroenterology 135, 956-968, 2008
Cited by (1)
-
15
- Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma
-
KOOPMANN J
Cancer Epidemiol Biomarkers Prev 13, 487-491, 2004
Cited by (1)
-
16
- Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
-
KOLB A
Cancer Biol Ther 4, 740-746, 2005
Cited by (1)
-
17
- Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent
-
TUCK AB
Breast Cancer Res Threat 70, 197-204, 2001
Cited by (1)
-
18
- Advances in the Treatment of Pancreatic Cancer : Limitations of Surgery and Evaluation of New Therapeutic Strategies
-
YOKOYAMA YUKIHIRO , NIMURA YUJI , NAGINO MASATO
Surg Today 39(6), 466-475, 2009-06-01
Ichushi Web References (91) Cited by (5)
-
19
- Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
-
WEBER. G. F.
Science 271, 509-512, 1996
DOI Cited by (35)
-
20
- Identification of dual alpha4 beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin
-
BAYLESS KJ
J Biol Chem 276, 13483-13489, 2001
Cited by (2)
-
21
- The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model
-
OATES A. J.
Oncogene 13, 97-104, 1996
Cited by (5)
-
22
- Plasma osteopontin : associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma
-
HOTTE SJ
Cancer 95, 506-512, 2002
DOI Cited by (3)
-
23
- A New Peritoneal Dissemination Model Established from the Human Pancreatic Cancer Cell Line
-
NISHIMORI Hidefumi , YASOSHIMA Takahiro , DENNO Ryuichi , SHISHIDO Takayuki , HATA Fumitake , HONMA Toshio , URA Hideki , YAMAGUCHI Koji , YAGIHASHI Atsuhito , TANAKA Hiroshi , KAWAGUCHI Satoshi , KAMIGUCHI Kenjiro , ISOMURA Hiroshi , SATO Noriyuki , HIRATA Koichi
Pancreas 22(4), 348-356, 2001-05-01
References (28) Cited by (2)
-
24
- Establishment and Characterization of Human Pancreatic Carcinoma Lines with High Metastatic Potential in the Liver of Nude Mice
-
SHISHIDO Takayuki , YASOSHIMA Takahiro , HIRATA Koichi , DENNO Ryuichi , MUKAIYA Mitsuhiro , URA Hideki , YAMAGUCHI Koji , KAWAGUCHI Satoshi , SATO Noriyuki
Surg Today 29(6), 519-525, 1999-06
Ichushi Web References (36) Cited by (5)
-
25
- A Novel Nude Mouse Model of Liver Metastasis and Peritoneal Dissemination From the Same Human Pancreatic Cancer Line
-
NISHIMORI Hidefumi , YASOSHIMA Takahiro , HATA Fumitake , DENNO Ryuichi , YANAI Yoshiyuki , NOMURA Hiroki , TANAKA Hiroshi , KAMIGUCHI Kenjiro , SATO Noriyuki , HIRATA Koichi
Pancreas 24(3), 242-250, 2002-04-01
References (39) Cited by (1)
-
26
- A new liver metastatic and peritoneal dissemination model established from the same human pancreatic cancer cell line : analysis using cDNA macroarray
-
NOMURA H
Clin Exp Metastasis 19, 391-399, 2002
DOI Cited by (3)
-
27
- Obstructive uropathy in the mouse : role of osteopontin in interstitial fibrosis and apoptosis
-
OPHASCHAROENSUK V.
Kidney Int 56, 571-580, 1999
DOI Cited by (5)
-
28
- Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling
-
AGRAWAL D
J. Natl. Cancer Inst. 94, 513-521, 2002
DOI Cited by (6)
-
29
- Osteopontin as a potential diagnostic biomarker for ovarian cancer
-
KIM JH
JAMA 13, 1671-1679, 2002
DOI Cited by (5)
-
30
- Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
-
YE QH
Nat Med 9, 416-423, 2003
DOI Cited by (15)
-
31
- <no title>
-
HANAHAN D.
Cell 100, 57-70, 2000
DOI Cited by (103)
-
32
- Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA
-
BEHREND E. I.
Cancer Res 54, 832-837, 1994
Cited by (5)
-
33
- Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts
-
MIYAUCHI A.
J Biol Chem 266, 20369-20374, 1991
Cited by (16)